ehealth radio network
How to Handle Stress Eating During COVID-19

How to Handle Stress Eating During COVID-19

December 30, 2020

 

John_Bartemus_26m9mc.png

 

Dr. John Bartemus, Founder of Functional Medicine Charlotte where he helps patients with autoimmunity, chronic infections and a diverse range of medical conditions joins eHealth Radio and the Health News Channel.


Listen to interview with host Eric Michaels and guest Dr. John Bartemus discuss the following:

  1. What is autoimmune disease?
  2. What are some causes of autoimmune disease?
  3. Why is eating more sometimes the key to losing weight?
  4. What is the perfect diet for autoimmune disease patients?
  5. Why is functional medicine the key to healing autoimmune disease?

Dr. John Bartemus is a chiropractic physician and certified functional medicine practitioner. He has a Bachelor of Science in Biology and Life Services and is a member of several prestigious medical organizations. Dr. Bartemus is the Founder of Functional Medicine Charlotte, where he helps patients with autoimmunity, chronic infections and a diverse range of medical conditions. He is also the international best-selling author of The Autoimmune Answer.


Website: functionalmedicinecharlotte.com

Social Media Links:
Instagram: instagram.com/functionalmedicinecharlotte 
Facebook: facebook.com/FunctionalMedicineCharlotte
Youtube: youtube.com/user/AccelerateChiro

The importance of Hydration during COVID, Mask Wearing and Flu Season!

The importance of Hydration during COVID, Mask Wearing and Flu Season!

December 26, 2020

 

AlexGalindez.jpg

 

Alex Galindez, the CEO of ROAR Organic, the amazing organic drink that is loaded with vitamins and electrolytes joins eHealth Radio and the Health News and Nutrition Channels.


Listen to interview with host Eric Michaels and guest Alex Galindez discuss the following:

  1. Tell me about your background and when you came to ROAR?
  2. What is Roar?
  3. What is your favorite flavor?
  4. Why is now more important than ever to stay hydrated?
  5. What can expect from ROAR in 2021?

Brand builder with 20 years of experience with start-up and developed brands. Alexandra (Alex) was part of the Red Bull Energy Drink and Glacéau VitaminWater and SmartWater launches in the United States.

Prior to her present role as CEO of ROAR Beverages, Alex Galindez led two major brand transformations as Chief Executive Officer of RUNA Beverages and as General Manager of BluePrint Functional Beverages, part of the Hain Celestial Group of Companies.

Prior to General Management, Alex had a long-standing career in Advertising and Marketing at companies such as Facebook, where she was part of the Global Marketing Solutions team, and Burger King where she was Director of Multi-cultural Marketing.

Alex began her career at Wunderman, a Young & Rubicam Global Marketing Agency Group after earning her Bachelor of Science Degree in Advertising and Marketing at the University of Miami.

 

roar_logo_09_360x.png

 

Website: https://roarorganic.com

Social Media Links:
Instagram: instagram.com/roarorganic
Facebook: facebook.com/ROARorganic

Michael and Paul Harney discuss The Hemp Division and CBD

Michael and Paul Harney discuss The Hemp Division and CBD

December 26, 2020

 

harney.jpg

 

Brothers Michael and Paul Harney, Co-Founders of The Hemp Division, a company committed to crafting the highest quality CBD and Hemp products, all From the Roots Up joins eHealth Radio and the CBD and Health Channels.


Listen to interview with host Eric Michaels and guests Michael and Paul Harney discuss the following:

  1. What inspired you to expand Harney & Sons tea with a division dedicated to Hemp and CBD Products?
  2. How has your experience been farming hemp plants from “the roots up” at the Harney & Sons headquarters?
  3. What are the health benefits of CBD?
  4. What separates The Hemp Division from the pack within the CBD industry?

In 2018, brothers Michael and Paul Harney embarked on a mission: create an all-new, extraordinary fusion of fine tea and premium CBD. Fueled by their 30+ years of combined tea experience, they decided to do it from the roots up and worked with hemp farmers to plant 7000 hemp plants on the Harney & Sons headquarters in Millerton, NY forming their new sister company: The Hemp Division.

Every day brings something new to The Hemp Division. From first planting and tending to drying, extracting, packing, and bottling, every moment goes towards creating great results. The Hemp Division now boasts a lively selection of Tea + CBD blends for all occasions, from hot and iced brews to sparkling beverages. For those who prefer to enjoy THD’s high-quality CBD in other ways, there are also tinctures and bath sundries, all richly infused with their own hemp extractions.

The Hemp Division is committed to crafting the highest quality products, all From the Roots Up.

Drink up and find your own path.

 

HempDivision_1.png

 

Website: thehempdivision.com

Social Media Links:
Facebook: facebook.com/thehempdivision
Instagram: instagram.com/thehempdivision

The importance of accurate and precise blood volume measurement in heart failure and critical care patients

The importance of accurate and precise blood volume measurement in heart failure and critical care patients

December 23, 2020

 

DXR_Michael_headshot80zvv.png

Michael Feldschuh, the CEO of Daxor, an innovative medical instrumentation and biotechnology company focused on blood volume measurement joins eHealth Radio and the Health News and Technology Channels.


Listen to interview with host Eric Michaels and guest Michael Feldschuh discuss the following:

  1. Can you tell me a bit about yourself and how you got interested in the medical technology field that led to your involvement with Daxor?
  2. Let’s talk about BVA-100 and its benefits to physicians? How does BVA-100 differentiate from other similar technologies?
  3. How does BVA-100 allow clinicians to provide better outcomes for their patients?
  4. Are there any recent studies that validate BVA?
  5. Please give us an overview of BVA-100 and how it improves outcomes for heart failure patients?

Daxor Corporation (NYSE: DXR) is an innovative medical instrumentation and biotechnology company focused on blood volume measurement. We developed and market the BVA-100® (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms. The BVA technology has the potential to improve hospital performance metrics in a broad range of surgical and medical conditions, including heart failure and critical care, by informing treatment strategies, resulting in significantly improved patient outcomes. Our mission is to partner with clinicians to incorporate BVA technology into standard clinical practice and improve the quality of life for patients.

 

Daxor_Logo_Update_RGB-red_1_88w98.png

 

Website: www.daxor.com

Social Media Links:
Facebook: facebook.com/Daxorcorp 
Linkedin: linkedin.com/company/daxorcorporation 
Twitter: twitter.com/DaxorBVA

What is DehydraTECH and how is it revolutionizing drug delivery for many industries

What is DehydraTECH and how is it revolutionizing drug delivery for many industries

December 19, 2020

 

Chris_Bunka_9sn2o.png

 

Chris Bunka, the CEO of Lexaria Bioscience, a Lexaria Bioscience Corp.’s proprietary drug delivery technology, DehydraTECH™, that improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier ingestion methods and increasing the effectiveness of fat-soluble active molecules, thereby lowering overall dosing joins eHealth Radio aand the Health News and Pharmaceutical Channels.


Listen to interview with host Eric Michaels and guest Chris Bunka discuss the following:

  1. Please tell us a little bit about yourself, how Lexaria Bioscience started and the development of the company’s technology?
  2. What exactly are DehydraTECH and its benefits?
  3. Can you talk about your recent announcement with British American Tobacco?
  4. What are fat-soluble active molecules and how can your technology lower overall dosing with pharmaceutical ingredients?
  5. What type of drugs and areas can DehydraTECH increase bio-absorption?

Lexaria Bioscience Corp.’s (OTCQX: LXRP, CSE: LXX) proprietary drug delivery technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier ingestion methods and increasing the effectiveness of fat-soluble active molecules, thereby lowering overall dosing. The Company’s technology can be applied to many different ingestible product formats, including foods, beverages, oral suspensions, tablets, and capsules.

DehydraTECH increases bio-absorption by up to 5-10x, reduces time of onset from 1 - 2 hours to 10 - 20 minutes, and masks unwanted tastes for orally administered bioactive molecules, including anti-virals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine, and other molecules.

Lexaria has licensed DehydraTECH to multiple companies including a world-leading tobacco producer for the development of smokeless, oral-based nicotine products and for use in industries that produce cannabinoid beverages, edibles, and oral products. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and over 60 patents pending worldwide.

 

Lexaria_Bioscience_Logo_Dark_PRINT.png

 

Website: lexariabioscience.com

Social Media Links:
Facebook: facebook.com/lexariabioscience
Linkedin: linkedin.com/company/lexaria-bioscience
Twitter: twitter.com/LexariaBioCorp

The Future of Medical Recalls

The Future of Medical Recalls

December 18, 2020

 

Joan_Melendez_Post72quy.png

 

Joan Melendez, the Founder and President at health-tech startup Xcelrate UDI joins eHealth Radio and the Health News and Technology Channels. Their technology, a medical device barcode scanning solution, identifies and prevents the use of recalled and faulty medical products and devices to improve patient safety at the point of care.


Listen to interview with host Eric Michaels and guest Joan Melendez discuss the following:

  1. What is a Unique Device Identifier, and why has it become so relevant in recent times?
  2. What kind of impact are medical recalls currently having on the healthcare industry and patients?
  3. How could full-scale adoption of your barcode scanning technology change healthcare - for patients and the industry as a whole?
  4. How can technology be better used across healthcare -- for communication, organisation, data storage?
  5. The Closed Loop Automation Solution you’ve partnered on has introduced an electronic patient implant card. How will this benefit patients?

Tip: If you’ve had a medical device implanted or are about to, ask your doctor about how they are ensuring your implants are safe for use and how you will be notified of quality issues should your implants be recalled after they are implanted.


Founder and President Joan Melendez leads the team at Xcelrate UDI. Having been in the healthcare industry since her teens, Joan has become a passionate advocate for the safety of patients and for innovation in healthcare.

Xcelrate UDI is a healthcare technology and consulting services company that leverages the power of UDI (unique device identifier) barcode scanning technology to bridge the information gaps between data sources (provided by manufacturers and the FDA) for medical devices and physical supplies. Their vision? To be the industry’s most trusted partner in advancing UDI adoption to improve compliance with medical devices and reduce patient risk at the point of care.

 

UDI_Black_Logo_Transparent_background88k8c.png

 

Website: www.xcelrateudi.com

Social Media Links:
Facebook: facebook.com/xcelrateudi 
Linkedin: linkedin.com/company/xcelrate-udi 
Instagram: instagram.com/xcelrateudi

Research shows that honey can be effective with respiratory illness

Research shows that honey can be effective with respiratory illness

December 16, 2020

 

Dr_Baljit_Khamba8o91q.png

 

Dr. Baljit Khamba, a clinic supervisor at Bastyr University Clinic and a core faculty member at Bastyr University California joins eHealth Radio and the Health News Channel.

Bastyr University is a nonprofit, private university offering doctoral, graduate and undergraduate degrees, with a multidisciplinary curriculum in science-based natural medicine. Recognized globally for its rigorous curriculum and strong research, the 42-year-old University has campuses in Kenmore, Washington, and San Diego, California. Bastyr's international faculty educate future leaders in the natural health arts and sciences, with an emphasis on integrating mind, body, spirit and nature.


Listen to interview with host Eric Michaels and guest Dr. Baljit Khamba discuss the following:

  1. Tell us how you and your colleagues came to this research idea.
  2. What evidence did the research show that honey can be effective with respiratory illness?
  3. Why is your immunity and respiratory health important right now?
  4. How can you incorporate honey into your daily routine to support your immune system?
  5. What are other ways people can boost their immune system?

Dr. Baljit Khamba is a clinic supervisor at Bastyr University Clinic and a core faculty member at Bastyr University California. She treats a variety of conditions but has special interest in nutritional approaches to anxiety, stress, depression, focus and attention, memory and cognition. She focuses on providing high quality care addressing the causes of disease and utilizes safe and effective natural treatments. She accepts patients and their families who are motivated to improve their health. Her emphasis is on disease prevention and health promotion through education and empowering her patients to become active participant in the management of their own health.

While completing bachelor and master’s degrees, she worked as a research analyst at the Centre for Addiction and Mental Health (CAMH), where she researched alcohol addiction and anxiety, as well as nutrition and mental health. Dr. Khamba also has experience working in integrative psychiatric clinics, as well as more generalized practice, as well as being involved with research projects at the University of Alberta on natural health product safety in psychiatric patients. Dr. Khamba also maintains a private telemedicine practice.

935b4b7e-2bfd-4462-b9e5-0a63be7e596570ec5153-0fd5-4425-a835-1246927b3b2e.jpg

Websites: https://bastyr.edu | https://bastyrclinic.org

A Holistic Approach to Helping Depression, Anxiety, and Memory Loss

A Holistic Approach to Helping Depression, Anxiety, and Memory Loss

December 12, 2020

 

Dr_Bob_DeMaria_20208rl00.jpeg

 

Dr. Bob DeMaria, the Founder of The Drugless Doctors, a chiropractic practice in Cleveland, OH and Naples, FL that also provides personalized nutrition, drugless lab testing, and breast thermography joins eHealth Radio and the Chiropractor and Mental Health Channels.


Listen to interview with host Eric Michaels and guest Dr. Bob DeMaria discuss the following:

  1. What is mental health?
  2. Why is there such an emphasis on mental health today?
  3. How can the food we consume affect our mental health?
  4. How can someone improve mental health conditions like depression and anxiety naturally?
  5. If someone wanted to begin a roadmap to improve their mental health today, what are the first three things they can do?

Dr. Bob DeMaria is an accomplished healthcare provider with over forty years experience helping individuals from all over the world without ever prescribing a single medication. His educational background includes a degree in Human Biology, specialties in Spinal Engineering and Natural Orthopedic Treatments, valedictorian of his chiropractic class at National University of Health Sciences, and an NHD degree.

He is the founder of The Drugless Doctors, a chiropractic and nutrition-based practice, with locations in Cleveland, Ohio and Naples, Florida. His extensive research and clinical observations have been the foundation for his eleven books, including the new, “Dr. Bob’s Drugless Guide to Mental Health,” which he co-wrote with his wife, Debbie.

An avid fan of life after 5pm, Dr. Bob enjoys riding his bicycle, playing bocce, and celebrating any occasion with his family.

 

Dr_Bob_logo_2xa77ad.png

 

Website: druglessdoctor.com

Social Media Links:
Instagram: instagram.com/druglessdoctor
Facebook: facebook.com/druglessdoctor
Twitter: twitter.com/druglessdoctor

JanOne, treating the opioid industry and bringing to market drugs with non-addictive pain-relieving properties

JanOne, treating the opioid industry and bringing to market drugs with non-addictive pain-relieving properties

December 11, 2020

 

Dr_Giordano_JAN6owco.jpg

 

Tony Giordano, PhD and Chief Scientific Officer of JanOne (NASDAQ: JAN), which is focused on developing treatments for diseases that cause severe pain joins eHealth Radio and and the Health News and Pain Management Channels.


Listen to interview with host Eric Michaels and guest Tony Giordano, PhD discuss the following:

  1. Can you tell me a bit about yourself and how you got interested in reducing the need for opioid prescriptions that led to your involvement with JanOne?
  2. Please give us an overview of JAN101 and its recent developments.
  3. It is estimated that 40% of opioid overdose deaths involve prescription opioids, how is JanOne tackling the issue?
  4. What is Jan’s main focus when treating diseases that cause pain to millions around the world?
  5. Could you please give us some insight on Jan’s treatment for PAD and how PAD can affect patients?

JanOne (NASDAQ: JAN) is focused on developing treatments for diseases that cause severe pain. By alleviating pain at the source, JanOne aims to reduce the need for opioid prescriptions to treat disease-associated pain that can lead to opioid abuse. The company is also exploring solutions for non-addictive pain medications. Its lead candidate JAN101 is for treating peripheral artery disease (PAD), a condition that affects over 8.5 million Americans. JAN101 demonstrated positive results in a Phase 2a clinical trial, and Phase 2b trials are expected to begin in early 2021. JanOne is dedicated to funding resources toward innovation, technology, and education for PAD, associated vascular conditions and neuropathic pain. JanOne continues to operate its legacy businesses under their current brand names, which are undergoing review to determine appropriate strategic alternatives

 

JanOne-logo_2x-2auvup.png

 

Website: https://janone.com

Social Media Links:
Facebook: facebook.com/JanOneOfficial 
Linkedin: linkedin.com/company/janone 
Twitter: twitter.com/JanOne

Genprex, reprogramming the course of cancer and diabetes

Genprex, reprogramming the course of cancer and diabetes

December 8, 2020

 

rodney_varner_headshot.jpg

 

Rodney Varner, the CEO of Genprex, a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes joins eHealth Radio and the Cancer Information Diabetes and Health News Channels.


Listen to interview with host Eric Michaels and guest Rodney Varner discuss the following:

  1. What inspires you at Genprex?
  2. Please give us an overview of Genprex’s gene therapies in development. What is it intended to treat, and how does it work?
  3. Could you talk more specifically about Genprex’s lead product candidate GPX-001?
  4. Could you please give us some insight about GPX-002, gene therapy for people with diabetes and what is it comprised of?
  5. What are the benefits of Genprex’s targeted therapies for people with non-small cell lung cancer?

Genprex, Inc. is a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new treatment options for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches.

 

Genprex_LOGObu36u.png

 

Website: genprex.com

Social Media Links:
Facebook: facebook.com/genprexinc 
Linkedin: linkedin.com/company/genprex 
Twitter: twitter.com/genprex

Play this podcast on Podbean App